Early evaluation of the safety, reactogenicity, and immune response after a single dose of modified vaccinia Ankara-Bavaria Nordic vaccine against mpox in children: a national outbreak response. (2023)

First Author: Ladhani SN
Attributed to:  COVID-19 Immunity - National Core Study (IMM-NCS) funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s1473-3099(23)00270-0

PubMed Identifier: 37336224

Publication URI: http://europepmc.org/abstract/MED/37336224

Type: Journal Article/Review

Volume: 23

Parent Publication: The Lancet. Infectious diseases

Issue: 9

ISSN: 1473-3099